ODIN PAVES THE WAY FOR BETTER DRUG DEVELOPMENT WITH OPEN INNOVATION IN SCIENCE
With 54,5 M DKK from the Novo Nordisk Foundation (Grant number NNF20SA0061466), we will establish a network of academic and industrial researchers, who can co-create research projects that will help pave the way for better and more efficient drugs and diagnostics in the future.
We believe that many minds are better than one - and therefore we work hard to unite contributors across the university-industry divide. This will help us gain a better understanding of disease at the molecular level, which is essential to accelerate drug discovery.
Therefore, with a starting point in unmet patient needs, ODIN funds research projects about biomarkers and target validation.
Feel free to use our data under the CC NY license.
We will only accept scientific outputs from ODIN projects.